Trade AnaptysBio - ANAB CFD

Add to favourite

21.51

4.72%

0.13

Low: 20.7

High: 21.77

Market Trading Hours* (UTC) Opens on Wednesday at 13:30

Mon - Fri: 13:30 - 20:00

Summary
Historical Data

Trading сonditions

Spread

0.13

Long position overnight fee

-0.023429%

Short position overnight fee

0.001207%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

5.00%

Stock exchange

United States of America

Commission on trade

Key Stats

Prev. Close	20.54
Open	20.8
1-Year Change	5.32%
Day's Range	20.7 - 21.77

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 22, 2025	21.51	1.44	7.17%	20.07	21.97	20.07
Apr 21, 2025	20.54	0.25	1.23%	20.29	20.97	19.62
Apr 17, 2025	20.45	1.70	9.07%	18.75	20.68	18.75
Apr 16, 2025	18.98	1.49	8.52%	17.49	18.99	17.48
Apr 15, 2025	18.05	0.47	2.67%	17.58	18.57	17.45
Apr 14, 2025	17.78	0.83	4.90%	16.95	18.01	16.68
Apr 11, 2025	17.09	1.29	8.16%	15.80	17.24	15.80
Apr 10, 2025	16.18	0.03	0.19%	16.15	16.35	15.46
Apr 9, 2025	16.81	0.36	2.19%	16.45	17.91	15.35
Apr 8, 2025	16.94	-0.53	-3.03%	17.47	18.58	16.78
Apr 7, 2025	17.69	0.13	0.74%	17.56	18.65	17.03
Apr 4, 2025	18.45	0.11	0.60%	18.34	19.15	17.95
Apr 3, 2025	19.17	0.71	3.85%	18.46	19.28	17.66
Apr 2, 2025	18.88	1.12	6.31%	17.76	19.75	17.33
Apr 1, 2025	18.34	0.14	0.77%	18.20	18.54	17.27
Mar 31, 2025	18.51	0.56	3.12%	17.95	18.75	17.71
Mar 28, 2025	18.86	0.26	1.40%	18.60	19.46	18.60
Mar 27, 2025	18.56	0.28	1.53%	18.28	18.85	17.39
Mar 26, 2025	18.11	-0.04	-0.22%	18.15	18.27	17.47
Mar 25, 2025	18.36	-0.10	-0.54%	18.46	18.75	17.79

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

1:1
2:1
3:1
5:1
10:1
20:1

Leverage

20:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

AnaptysBio Company profile

About AnaptysBio Inc

AnaptysBio, Inc. is a clinical stage biotechnology company. The Company is developing immunology therapeutic product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications. It develops its product candidates using its antibody discovery technology platform, which is based upon the natural process of antibody generation, known as somatic hypermutation (SHM), and replicates this natural process of antibody generation in vitro. Its product pipeline includes Imsidolimab, ANB030 (Rosnilimab), ANB032, JEMPERLI, GSK4069889 (cobolimab), GSK4074386 and CC-90006. its Imsidolimab is an antibody that inhibits the interleukin-36 receptor (IL-36R) for the treatment of multiple dermatological inflammatory diseases. ANB030 is an antibody that binds PD-1 in an agonistic manner to suppress T cell activity and anti-inflammatory effects in vivo.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, AnaptysBio Inc revenues decreased 16% to $63.2M. Net loss increased from $19.9M to $57.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development - Balancing increase of 22% to $92.6M (expense), Interest income decrease of 89% to $431K (income).

Industry:

Bio Therapeutic Drugs

10770 Wateridge Circle, Suite 210
SAN DIEGO
CALIFORNIA 92121
US

News

ECB interest-rate forecasts – Projections for the next five years

The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.

14:37, 10 April 2025

BlackRock shareholders: Who owns the most BLK stock?

BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.

13:46, 9 April 2025

Rendering of physical bitcoin tokens on black background

Bitcoin price predictions 2025–2050: third-party price target

We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.

10:28, 9 April 2025

Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target

Where will Tesla’s stock be in five years? Can the EV company keep its crown?

08:19, 9 April 2025

JasmyCoin price predictions 2025-2030: Third-party price target

How might JASMY behave in the future?

16:13, 8 April 2025

Signage outside the entrance of the Reserve Bank of Australia building in Sydney, Australia.

Australian interest-rate projections: where will rates be in 5 years?

As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.

21:37, 7 April 2025